a drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent the growth of new blood vessels that tumors need to grow. it is a type of nonsteroidal anti-inflammatory drug and a type of antiangiogenesis agent. rofecoxib was taken off the market in the u.s. because of safety concerns. also called vioxx.
出典:Wikipedia
出典:『Wikipedia』 (2011/06/17 08:44 UTC 版)
Rofecoxib (pronounced /ˌrɒfɨˈkɒksɪb/) is a nonsteroidal anti-inflammatory drug (NSAID) that has now been withdrawn over safety concerns. It was marketed by Merck & Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhoea. Rofecoxib was approved by the Food and Drug Administration (FDA) on May 20, 1999, and was marketed under the brand names Vioxx, Ceoxx, and Ceeoxx.